### Overview of Recent IPO Developments in India The Indian IPO market is currently witnessing significant activity with multiple companies launching their Initial Public Offerings (IPOs). Notable among these are Vidya Wires, Helloji Holidays, Methodhub Software, Classic Electrodes, and Corona Remedies. Each of these companies is at different stages of their IPO processes, with varying subscription statuses and grey market premiums (GMP). The IPO landscape is characterized by investor enthusiasm, particularly for Corona Remedies, which has seen a remarkable subscription rate. ### Breakdown of Current IPOs and Their Status 1. **Vidya Wires IPO** - **GMP Status**: The IPO is currently in its second day of GMP tracking. - **Key Details**: Information regarding the IPO price, subscription status, and allotment is being closely monitored [https://univest.in/blogs/vidya-wires-ipo-gmp-day-2]. 2. **Helloji Holidays IPO** - **GMP Status**: Similar to Vidya Wires, Helloji Holidays is also in its second day of GMP tracking. - **Key Details**: Investors are looking for updates on the IPO price and subscription status [https://univest.in/blogs/helloji-holidays-ipo-gmp-day-2]. 3. **Methodhub Software IPO** - **GMP Status**: Currently on its third day of GMP tracking. - **Key Details**: The IPO is under scrutiny for its price and subscription metrics [https://univest.in/blogs/methodhub-software-ipo-gmp-day-3]. 4. **Classic Electrodes IPO** - **GMP Status**: In its second day of GMP tracking. - **Key Details**: Investors are keen on the IPO price and subscription status [https://univest.in/blogs/classic-electrodes-ipo-gmp-2]. 5. **Corona Remedies IPO** - **GMP Status**: The IPO has garnered significant attention, with a subscription rate of 144x. - **Key Details**: The IPO opened on December 8, 2025, and closed on December 10, 2025, with a price band of ₹1008 to ₹1062 per share. The allotment date is December 11, 2025, and it is set to list on December 15, 2025 [https://ipowatch.in/corona-remedies-ipo-date-review-price-allotment-details]. ### Supporting Evidence and Data - **Subscription Rates**: - Corona Remedies IPO was subscribed 39.54x by the end of its third day, indicating strong investor interest [https://www.livemint.com/market/ipo/corona-remedies-ipo-day-3-issue-subscribed-9-96x-so-far-heres-gmp-subscription-status-apply-or-not]. - **GMP Insights**: - As of December 10, the GMP for Corona Remedies was reported at ₹270, suggesting a potential listing price of approximately ₹1,332, which is about 25.42% higher than the upper price band [https://www.livemint.com/market/ipo/corona-remedies-ipo-day-3-issue-subscribed-9-96x-so-far-heres-gmp-subscription-status-apply-or-not]. ### Conclusion and Future Outlook In summary, the current IPO landscape in India is vibrant, with several companies actively engaging investors. **Key takeaways include**: 1. **High Subscription Rates**: Particularly for Corona Remedies, indicating robust market confidence. 2. **Ongoing Monitoring**: Investors are advised to keep an eye on GMP trends and subscription statuses for all IPOs. 3. **Upcoming Listings**: The listing of Corona Remedies on December 15, 2025, is highly anticipated, with expectations of strong market performance. Investors should remain informed and consider the potential long-term benefits of participating in these IPOs, especially given the positive financial indicators from companies like Corona Remedies [https://ipowatch.in/corona-remedies-ipo-date-review-price-allotment-details].